Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

Allegati

13/ago/2019 14:42:50 KBV Research Contatta l'autore

According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

 

pharmacogenomics-market.jpg

The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025).

 

The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025).

 

The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025).

 

Full Report: https://www.kbvresearch.com/pharmacogenomics-market/

 

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

 

Global Pharmacogenomics Market Segmentation

 

By Technology

Sequencing

Polymerase Chain Reaction

Electrophoresis

Mass Spectrometry

Microarray

Others

 

By Application

Oncology

Psychiatry

Infectious Diseases

Neurological Diseases

Pain management

Cardiovascular Diseases

Others

 

By End User

Hospitals and Clinics

Research Institutions

Academic Institutes

 

By Geography

 

North America

US

Canada

Mexico

Rest of North America

 

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

 

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

 

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

 

Companies Profiled

Abbott Laboratories

Empire Genomics LLC

Illumina, Inc.

Oneome LLC

Myriad Genetics Inc.

Thermo Fisher Scientific, Inc.

Teva Pharmaceuticals Industries Ltd.

Bayer AG

Opko Health, Inc.

Becton, Dickinson and Company

 

Unique Offerings from KBV Research

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

 

Pharmacogenomics Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

 

blog comments powered by Disqus
Comunicati.net รจ un servizio offerto da Factotum Srl